Indivior Pharmaceuticals Inc reported earnings of $ 1.32 per INDV share on Oct 29, 2026, beating analysts' expectations by
| Report Date | Oct 29, 2026 |
|---|---|
| Forecasted EPS | $ 1.06 |
| Earnings Per Share (Surprise) | $ 1.32 (+$ 0.26) |
| Last Year's EPS | $ 0.615 |
| EPS YoY Change |
Out of the last 18 earnings reporting periods, Indivior Pharmaceuticals Inc beat analysts’ expectations 12 times and fell short of expectations 1 time(s). Indivior Pharmaceuticals Inc reported earnings per share of $ 1.32 in the last report surpassing an estimated EPS of $ 1.06 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Oct 29, 2026 | $ 1.06 | $ 1.32 | $ 0.72 | |
| Aug 3, 2026 | $ 0.869 | $ 1.15 | $ 0.51 | |
| Apr 30, 2026 | $ 0.64 | $ 0.96 | $ 0.41 | |
| Feb 26, 2026 | $ 0.65 | $ 0.82 | $ 0.32 | |
| Oct 30, 2025 | $ 0.38 | $ 0.72 | $ 0.54 | |
| Jul 31, 2025 | $ 0.26 | $ 0.51 | $ 0.44 | |
| Apr 24, 2025 | $ 0.22 | $ 0.41 | $ 0.37 | |
| Feb 20, 2025 | $ 0.32 | $ 0.32 | $ 0.43 | |
| Oct 24, 2024 | $ 0.31 | $ 0.54 | $ 0.34 | |
| Jul 25, 2024 | $ 0.40 | $ 0.44 | $ 0.39 | |
| Apr 25, 2024 | $ 0.42 | $ 0.37 | $ 0.40 | |
| Feb 22, 2024 | $ 0.28 | $ 0.43 | $ 0.27 | |
| Nov 9, 2023 | $ 0.30 | $ 0.34 | $ 0.29 | |
| Jul 27, 2023 | $ 0.22 | $ 0.39 | $ 0.30 | |
| Apr 27, 2023 | - | $ 0.40 | - | - |
| Feb 16, 2023 | - | $ 0.27 | - | - |
| Oct 27, 2022 | - | $ 0.29 | - | - |
| Jul 28, 2022 | - | $ 0.30 | - | - |
Indivior Pharmaceuticals Inc’s stock was trading at $ 34.77 on Oct 28, 2026 a day before the last earnings report was released.Following the release of the earnings report, INDV’s price increased to $ 35.37 on Oct 30, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Oct 29, 2026 | $ 1.32 | $ 34.77 | $ 35.37 | |
| Aug 3, 2026 | $ 1.15 | $ 40.01 | $ 36.50 | |
| Apr 30, 2026 | $ 0.96 | $ 34.15 | $ 37.66 | |
| Feb 26, 2026 | $ 0.82 | $ 33.63 | $ 32.72 | |
| Oct 30, 2025 | $ 0.72 | $ 25.24 | $ 29.37 | |
| Jul 31, 2025 | $ 0.51 | $ 17.40 | $ 21.05 | |
| Apr 24, 2025 | $ 0.41 | $ 9.45 | $ 11.56 | |
| Feb 20, 2025 | $ 0.32 | $ 10.91 | $ 8.45 | |
| Oct 24, 2024 | $ 0.54 | $ 8.56 | $ 9.00 | |
| Jul 25, 2024 | $ 0.44 | $ 10.88 | $ 12.79 | |
| Apr 25, 2024 | $ 0.37 | $ 18.81 | $ 17.58 | |
| Feb 22, 2024 | $ 0.43 | $ 17.50 | $ 21.28 | |
| Nov 9, 2023 | $ 0.34 | $ 19.30 | $ 15.97 | |
| Jul 27, 2023 | $ 0.39 | $ 24.39 | $ 22.77 | |
| Apr 27, 2023 | $ 0.40 | $ 18.20 | $ 18.75 | |
| Feb 16, 2023 | $ 0.27 | $ 23.51 | $ 20.49 | |
| Oct 27, 2022 | $ 0.29 | $ 16.67 | $ 19.86 | |
| Jul 28, 2022 | $ 0.30 | $ 18.25 | $ 18.85 |
Indivior Pharmaceuticals Inc released its most recent earnings reports in October 2026, August 2026, April 2026, February 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Indivior Pharmaceuticals Inc beat analysts’ expectations during the last earnings period by
